Literature DB >> 7896537

Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.

D Fan1, G Poste, C Seid, L E Earnest, T Bull, R K Clyne, I J Fidler.   

Abstract

The purpose of this study was to identify calcium channel and calmodulin antagonists effective in increasing the cytotoxic effects of several chemotherapeutic drugs against UV-2237 murine fibrosarcoma MDR cells. Among 8 compounds tested at nontoxic concentrations, flupentixol, a piperazine-substituted thioxanthene, was the most potent in enhancing the cytotoxicity of anticancer drugs commonly associated with the multidrug resistant (MDR) phenotype, such as Adriamycin, actinomycin D, vinblastine, and vincristine, but not 5-fluorouracil, a drug usually unaffected by MDR. The chemosensitizing effects of flupentixol were produced by increasing intracellular drug accumulation via a mechanism unrelated to the binding of the plasma membrane P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7896537     DOI: 10.1007/bf00873959

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  38 in total

1.  Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial.

Authors:  R L Miller; R M Bukowski; G T Budd; J Purvis; J K Weick; K Shepard; K K Midha; R Ganapathi
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

2.  Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.

Authors:  H Hamada; E Okochi; T Oh-hara; T Tsuruo
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

Review 3.  Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.

Authors:  D Kessel
Journal:  Cancer Surv       Date:  1986

Review 4.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.

Authors:  A J Bitonti; A Sjoerdsma; P P McCann; D E Kyle; A M Oduola; R N Rossan; W K Milhous; D E Davidson
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

7.  Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.

Authors:  J M Ford; W C Prozialeck; W N Hait
Journal:  Mol Pharmacol       Date:  1989-01       Impact factor: 4.436

8.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Authors:  R F Ozols; R E Cunnion; R W Klecker; T C Hamilton; Y Ostchega; J E Parrillo; R C Young
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

9.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

10.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

View more
  6 in total

1.  Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2).

Authors:  A R Alexanian; N S Arutyunian
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.

Authors:  S J Kim; H Uehara; T Karashima; M Mccarty; N Shih; I J Fidler
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

Review 3.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Authors:  Young Hee Choi; Ai-Ming Yu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Modulating cancer cell survival by targeting intracellular cholesterol transport.

Authors:  Omer F Kuzu; Raghavendra Gowda; Mohammad A Noory; Gavin P Robertson
Journal:  Br J Cancer       Date:  2017-07-11       Impact factor: 7.640

5.  The Impact of Melatonin on Colon Cancer Cells' Resistance to Doxorubicin in an in Vitro Study.

Authors:  Magdalena Fic; Agnieszka Gomulkiewicz; Jedrzej Grzegrzolka; Marzenna Podhorska-Okolow; Maciej Zabel; Piotr Dziegiel; Karolina Jablonska
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

6.  The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer.

Authors:  Chao Dong; Yin Chen; Hongjian Li; Yi Yang; Hongtao Zhang; Kunbin Ke; Xi-Nan Shi; Xu Liu; Ling Li; Jing Ma; Hsiang-Fu Kung; Ceshi Chen; Marie Chia-Mi Lin
Journal:  Int J Biol Sci       Date:  2019-06-02       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.